SWK CEO sees core as commercialized life science products
SWK Holdings (SWKH) is a specialized finance company with a specific focus on opportunities in the global healthcare sector. In an exclusive interview with The Fly, the company's CEO Winston Black talked about SWK Holdings and its focus: "In essence we are a specialized life science focused, finance company. We focus on commercial opportunities and we can invest in those opportunities in a handful of ways by either owning an asset outright - for example one of our earliest transactions when you started the business in 2012 was purchasing a beta blocker from GSK with an operating partner -, owning the royalty streams that are produced by the sales of those products, which is 20% of our business today, or by doing what we call structured credit. Earlier commercial stage life science companies have products and are looking to grow and reach the next value inflection milestone. That's really our core kind of business and focus: commercialized life science products." "Meet the Company" is The Fly's recurring series of exclusive short interviews with Executive Officers to offer a deeper look inside the company. The remainder of this interview to follow.